Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analyses

BMJ Open. 2017 Jan 17;7(1):e012360. doi: 10.1136/bmjopen-2016-012360.

Abstract

Objectives: This study presents a cost-effectiveness analysis comparing hydrophilic coated to uncoated catheters for patients performing urinary intermittent catheterisation. A national budget impact analysis is also included to evaluate the impact of intermittent catheterisation for management of bladder dysfunctions over a period of 5 years.

Design: A Markov model (lifetime horizon, 1 year cycle length) was developed to project health outcomes (life years and quality-adjusted life years) and economic consequences related to patients using hydrophilic coated or uncoated catheters. The model was populated with catheter-related clinical efficacy data retrieved from randomised controlled trials and quality-of-life data (utility weights) from the literature. Cost data (EUR, 2015) were estimated on the basis of healthcare resource consumption derived from an e-survey addressed to key opinion leaders in the field.

Setting: Italian Healthcare Service perspective.

Population: Patients with spinal cord injury performing intermittent urinary catheterisation in the home setting.

Main outcome measures: Incremental cost-effectiveness and cost-utility ratios (ICER and ICUR) of hydrophilic coated versus uncoated catheters and associated healthcare budget impact.

Results: The base-case ICER and ICUR associated with hydrophilic coated catheters were €20 761 and €24 405, respectively. This implies that hydrophilic coated catheters are likely to be cost-effective in comparison to uncoated ones, as proposed Italian threshold values range between €25 000 and €66 400. Considering a market share at year 5 of 89% hydrophilic catheters and 11% uncoated catheters, the additional cost for Italy is approximately €12 million in the next 5 years (current market share scenario for year 0: 80% hydrophilic catheters and 20% uncoated catheters).

Conclusions: Considered over a lifetime, hydrophilic coated catheters are potentially a cost-effective choice in comparison to uncoated ones. These findings can assist policymakers in evaluating intermittent catheterisation in patients with spinal cord injury.

Keywords: budget impact analysis; cost-effectiveness analysis; hydrophilic coated catheters; intermittent urinary catheterisation; uncoated catheters.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Budgets
  • Cost of Illness
  • Cost-Benefit Analysis
  • Health Resources / economics
  • Health Resources / statistics & numerical data
  • Hematuria / economics*
  • Hematuria / epidemiology
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Intermittent Urethral Catheterization / economics*
  • Intermittent Urethral Catheterization / instrumentation
  • Italy / epidemiology
  • Markov Chains
  • Observational Studies as Topic
  • Quality-Adjusted Life Years
  • Randomized Controlled Trials as Topic
  • Spinal Cord Injuries / economics
  • Urinary Tract Infections / economics*
  • Urinary Tract Infections / epidemiology